ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

Researchers from CIIMAR and the University of Helsinki have discovered a new biochemical modification in natural ...

The breakthrough addresses a longstanding challenge. Researchers make remarkable breakthrough that could transform common ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

An international team of scientists has uncovered strong evidence that respiratory syncytial virus (RSV) infection in early ...

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its ...

New study shows RSV infection in early infancy can raise asthma risk later, especially in children with allergic family ...

The analysis, conducted by Pentara Corporation in collaboration with scientists from ProMIS, provides important new evidence that plasma phosphorylated tau (pTau181 and pTau217) can serve as a ...

China's control over critical supply chains threatens U.S. national security in artificial intelligence, quantum computing ...

Fever slows seasonal flu by blocking viral replication, but bird-flu strains resist heat. New research reveals why—and what ...

An HPV vaccine delivered into the nose can treat cervical tumors in mice. The vaccine targets a cancer protein produced by the virus.

As reported by the South China Morning Post ( SCMP ), the team found that the faeces of yaks, Tibetan sheep, antelope, cattle, horses, and kiangs host thousands of microbial species that have never ...